Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS

Most read article(s)

  • You have access
    The Rheumatologist’s Role in COVID-19
    RANDY Q. CRON and W. WINN CHATHAM
    The Journal of Rheumatology May 1 2020, 47 (5) 639-642; DOI: https://doi.org/10.3899/jrheum.200334
  • Open Access
    Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
    HARVEY MOLDOFSKY, HERBERT W. HARRIS, W. TAD ARCHAMBAULT, TERENCE KWONG and SETH LEDERMAN
    The Journal of Rheumatology December 1 2011, 38 (12) 2653-2663; DOI: https://doi.org/10.3899/jrheum.110194
  • You have access
    COVID-19 and Rheumatic Diseases: It Is Time to Better Understand This Association
    Claudia D.L. Marques on behalf of the ReumaCoV Brasil Study Group
    The Journal of Rheumatology March 1 2021, 48 (3) 318-320; DOI: https://doi.org/10.3899/jrheum.201541
  • You have access
    The Effect of HLA-B27 on Susceptibility and Severity of COVID-19
    James T. Rosenbaum, Hedley Hamilton, Michael H. Weisman, John D. Reveille, Kevin L. Winthrop and Dongseok Choi
    The Journal of Rheumatology April 1 2021, 48 (4) 621-622; DOI: https://doi.org/10.3899/jrheum.200939
  • You have access
    Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?
    David Jayne
    The Journal of Rheumatology April 1 2021, 48 (4) 479-481; DOI: https://doi.org/10.3899/jrheum.201351
  • Open Access
    Risk of Adverse Outcomes in Hospitalized Patients With Autoimmune Disease and COVID-19: A Matched Cohort Study From New York City
    Adam S. Faye, Kate E. Lee, Monika Laszkowska, Judith Kim, John William Blackett, Anna S. McKenney, Anna Krigel, Jon T. Giles, Runsheng Wang, Elana J. Bernstein, Peter H.R. Green, Suneeta Krishnareddy, Chin Hur and Benjamin Lebwohl
    The Journal of Rheumatology March 1 2021, 48 (3) 454-462; DOI: https://doi.org/10.3899/jrheum.200989
  • You have access
    Inflammatory Joint Diseases and Risk of Cardiovascular Disease in Modern Rheumatology
    Inger Jorid Berg and Sella A. Provan
    The Journal of Rheumatology March 1 2021, 48 (3) 311-313; DOI: https://doi.org/10.3899/jrheum.201134
  • You have access
    Raynaud Phenomenon With Lingual Involvement in a 6-year-old Female
    Julia A. Hunter, Deborah M. Levy and Roberta A. Berard
    The Journal of Rheumatology March 1 2021, 48 (3) 465-466; DOI: https://doi.org/10.3899/jrheum.200258
  • You have access
    COVID-19 in Patients With Connective Tissue Disease-related Interstitial Lung Disease
    Linh Truong, Lila Pourzand and Elizabeth R. Volkmann
    The Journal of Rheumatology March 1 2021, 48 (3) 468-470; DOI: https://doi.org/10.3899/jrheum.201064
  • Open Access
    Propensity Score Methods in Rare Disease: A Demonstration Using Observational Data in Systemic Lupus Erythematosus
    Ibrahim Almaghlouth, Eleanor Pullenayegum, Dafna D. Gladman, Murray B. Urowitz and Sindhu R. Johnson
    The Journal of Rheumatology March 1 2021, 48 (3) 321-325; DOI: https://doi.org/10.3899/jrheum.200254

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire